Omics technologies improving breast cancer research and diagnostics

A Orsini, C Diquigiovanni, E Bonora - International Journal of Molecular …, 2023 - mdpi.com
Breast cancer (BC) has yielded approximately 2.26 million new cases and has caused
nearly 685,000 deaths worldwide in the last two years, making it the most common …

Breast cancer vaccines; A comprehensive and updated review

SIS Al-Hawary, EAM Saleh, NA Mamajanov… - … -Research and Practice, 2023 - Elsevier
Abstract According to the International Agency for Research on Cancer, breast cancer is
more common than lung cancer globally. By 2040, mortality from breast cancer will rise by …

Molecular mechanisms of multi-omic regulation in breast cancer

S Ochoa, E Hernández-Lemus - Frontiers in Oncology, 2023 - frontiersin.org
Breast cancer is a complex disease that is influenced by the concurrent influence of multiple
genetic and environmental factors. Recent advances in genomics and other high throughput …

Precision medicine in breast cancer

P Papalexis, VE Georgakopoulou… - Molecular and …, 2024 - spandidos-publications.com
Precision medicine in breast cancer is a revolutionary approach that customizes diagnosis
and treatment based on individual and tumor characteristics, departing from the traditional …

[HTML][HTML] Implications of agile values in software engineering for agility in breast cancer treatment: protocol for a comparative study

Y Odeh, M Al-Balas - JMIR Research Protocols, 2023 - researchprotocols.org
Background Breast cancer treatment has been described as a dynamic and patient-centered
approach that emphasizes adaptability and flexibility throughout the treatment process …

Role of PD‐1 in modulating IFN‐γ‐CXCL9/10‐CXCR3 signaling in breast cancer

L Hong, F Huang, Z Hu, Q Dong, Y Kong… - … of Biochemical and …, 2024 - Wiley Online Library
Breast cancer represents a significant health burden globally, necessitating ongoing
advancements in treatment strategies for improved patient outcomes. Immunotherapy …

Screening of potential hub genes and key pathways associated with breast cancer by bioinformatics tools

A Oumeddour - Medicine, 2023 - journals.lww.com
Breast cancer (BC) remains the leading cause of cancer-related death in women worldwide.
The development of new targeted therapies that may improve patient survival remains an …

Morphological Dependence of Breast Cancer Cell Responses to Doxorubicin on Micropatterned Surfaces

J Zheng, R Sun, H Chen, T Zeng, T Yoshitomi… - Polymers, 2022 - mdpi.com
Cell morphology has been widely investigated for its influence on the functions of normal
cells. However, the influence of cell morphology on cancer cell resistance to anti-cancer …

Molecular Profiling and Personalized Medicine in Drug-Resistant Breast Cancer

L Mabonga, A Chatziioannou, Z Dlamini - Overcoming Breast Cancer …, 2024 - Springer
The utilization of molecular profiling techniques and personalized medicine approaches in
the management of breast cancer is driven by molecular targets that can selectively target …

PIK3CA mutation presence as luminal breast cancer chemoresistance prognostic marker.

MO Volodimirovich, SI Ivanovich… - Onkologia i …, 2024 - search.ebscohost.com
Breast Cancer (BC) is the major cause of morbidity and mortality among women in Ukraine
and throughout the world, is characterized by a diverse set of gene alterations, the …